4//SEC Filing
Corvese Brian 4
Accession 0000950170-23-046776
CIK 0001840229other
Filed
Sep 5, 8:00 PM ET
Accepted
Sep 6, 5:02 PM ET
Size
5.3 KB
Accession
0000950170-23-046776
Insider Transaction Report
Form 4
Corvese Brian
Director
Transactions
- Award
Common Stock
2023-09-01$1.46/sh+12,244$17,876→ 329,523 total
Footnotes (2)
- [F1]The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs were received in lieu of cash retainers for board and committee compensation. The RSUs will vest one month from the grant date.
- [F2]In Table 1 of the Form 4 filed on June 2, 2023, the amount of securities acquired and price (column 4) and amount of securities beneficially owned following reported transaction (column 5) were erroneously reported. On June 1, 2023, 9,931 RSUs were acquired at a price of $1.80 each, resulting in a total amount of securities beneficially owned following the reported transaction of 317,279 instead of 317,505 as erroneously reported.
Documents
Issuer
MiNK Therapeutics, Inc.
CIK 0001840229
Entity typeother
Related Parties
1- filerCIK 0001393207
Filing Metadata
- Form type
- 4
- Filed
- Sep 5, 8:00 PM ET
- Accepted
- Sep 6, 5:02 PM ET
- Size
- 5.3 KB